SOD1 and amyotrophic lateral sclerosis: A focus on cerebrospinal fluid (CSF) biomarkers allows for interrogation of CNS protein changes that may differentiate disease pathways among sporadic and genetic forms of ALS, TDP- 43 and SOD1 pathologies, as well as provide tools allowing for early diagnosis and monitoring of disease activity.